Justin Harold

717 total citations
18 papers, 186 citations indexed

About

Justin Harold is a scholar working on Oncology, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Justin Harold has authored 18 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Obstetrics and Gynecology and 6 papers in Surgery. Recurrent topics in Justin Harold's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (5 papers) and HER2/EGFR in Cancer Research (3 papers). Justin Harold is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (5 papers) and HER2/EGFR in Cancer Research (3 papers). Justin Harold collaborates with scholars based in United States. Justin Harold's co-authors include Joan Tymon‐Rosario, Alessandro D. Santin, Burak Zeybek, Dennis Mauricio, Levent Mutlu, Gulden Menderes, Vaagn Andikyan, Blair McNamara, Mitchell Clark and Gary Altwerger and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Justin Harold

16 papers receiving 185 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin Harold United States 8 73 65 48 38 37 18 186
Alejandra Wernicke Argentina 10 99 1.4× 63 1.0× 59 1.2× 45 1.2× 36 1.0× 33 236
Jana Drozenová Czechia 8 66 0.9× 26 0.4× 49 1.0× 45 1.2× 18 0.5× 29 202
S. Suchetha India 9 55 0.8× 71 1.1× 48 1.0× 82 2.2× 32 0.9× 35 235
Hanmei Lou China 6 96 1.3× 51 0.8× 19 0.4× 16 0.4× 12 0.3× 14 154
Jennifer X. Ji Canada 7 33 0.5× 32 0.5× 107 2.2× 56 1.5× 31 0.8× 9 219
Hélène Vanacker France 9 87 1.2× 32 0.5× 54 1.1× 37 1.0× 29 0.8× 33 226
Elizabeth V. Connor United States 6 44 0.6× 45 0.7× 53 1.1× 26 0.7× 55 1.5× 12 156
Ari Reiss Israel 6 37 0.5× 35 0.5× 65 1.4× 33 0.9× 33 0.9× 20 169
Yen‐Hou Chang Taiwan 6 37 0.5× 70 1.1× 67 1.4× 111 2.9× 62 1.7× 12 207
Eric Rios‐Doria United States 8 33 0.5× 159 2.4× 25 0.5× 104 2.7× 34 0.9× 26 205

Countries citing papers authored by Justin Harold

Since Specialization
Citations

This map shows the geographic impact of Justin Harold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Harold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Harold more than expected).

Fields of papers citing papers by Justin Harold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Harold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Harold. The network helps show where Justin Harold may publish in the future.

Co-authorship network of co-authors of Justin Harold

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Harold. A scholar is included among the top collaborators of Justin Harold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Harold. Justin Harold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
McNamara, Blair, et al.. (2023). HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma. Cancers. 15(16). 4085–4085. 4 indexed citations
2.
McNamara, Blair, Levent Mutlu, Tobias M.P. Hartwich, et al.. (2023). Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers. International Journal of Molecular Sciences. 24(10). 8873–8873. 8 indexed citations
3.
Harold, Justin, et al.. (2023). Isolated torsion of the utero‐ovarian ligament. SHILAP Revista de lepidopterología. 11(11). e8114–e8114. 3 indexed citations
4.
Han, Chanhee, Blair McNamara, Stefania Bellone, et al.. (2023). The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivo. Gynecologic Oncology. 170. 172–178. 5 indexed citations
5.
McNamara, Blair, Levent Mutlu, Justin Harold, et al.. (2023). Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. Annals of Surgical Oncology. 30(9). 5597–5609. 8 indexed citations
6.
McNamara, Blair, Yifan Chang, Levent Mutlu, Justin Harold, & Alessandro D. Santin. (2023). Pembrolizumab with chemotherapy, with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer. Expert Opinion on Biological Therapy. 23(3). 227–233. 2 indexed citations
7.
Santin, Alessandro D., Blair McNamara, Eric R. Siegel, et al.. (2023). Preliminary results of a phase II trial with sacituzumab govitecan-hziy in patients with recurrent endometrial carcinoma overexpressing Trop-2.. Journal of Clinical Oncology. 41(16_suppl). 5599–5599. 12 indexed citations
8.
Mutlu, Levent, Joan Tymon‐Rosario, Justin Harold, & Gulden Menderes. (2022). Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer. Expert Review of Anticancer Therapy. 22(6). 633–645. 19 indexed citations
9.
Harold, Justin, Diego Manavella, Eric R. Siegel, et al.. (2022). BAY1895344, a novel ataxia telangiectasia and RAD3-related (ATR) inhibitor, is active in vivo against ATRX mutated uterine leiomyosarcoma (212). Gynecologic Oncology. 166. S118–S118.
10.
Mutlu, Levent, Justin Harold, Joan Tymon‐Rosario, & Alessandro D. Santin. (2022). Immune checkpoint inhibitors for recurrent endometrial cancer. Expert Review of Anticancer Therapy. 22(3). 249–258. 13 indexed citations
11.
12.
Mauricio, Dennis, Burak Zeybek, Joan Tymon‐Rosario, Justin Harold, & Alessandro D. Santin. (2021). Immunotherapy in Cervical Cancer. Current Oncology Reports. 23(6). 61–61. 66 indexed citations
13.
Tymon‐Rosario, Joan, Eric R. Siegel, Stefania Bellone, et al.. (2021). Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu. Gynecologic Oncology. 163(1). 93–99. 20 indexed citations
14.
Mauricio, Dennis, Emily Webster, Justin Harold, et al.. (2021). Two-Port Robotic Laparoscopic Hysterectomy. Journal of Minimally Invasive Gynecology. 28(11). S155–S155.
15.
Mauricio, Dennis, Justin Harold, Joan Tymon‐Rosario, Burak Zeybek, & Alessandro D. Santin. (2020). Novel mesothelin antibody-drug conjugates: current evidence and future role in the treatment of ovarian cancer. Expert Opinion on Biological Therapy. 21(8). 1087–1096. 5 indexed citations
16.
Harold, Justin, Erin Isaacson, & Anna Palatnik. (2019). <p>Femoral fracture in pregnancy: a case series and review of clinical management</p>. International Journal of Women s Health. Volume 11. 267–271. 7 indexed citations
17.
Harold, Justin, Denise Uyar, Janet S. Rader, et al.. (2019). Adipose-only sentinel lymph nodes: a finding during the adaptation of a sentinel lymph node mapping algorithm with indocyanine green in women with endometrial cancer. International Journal of Gynecological Cancer. 29(1). 53–59. 8 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandra Wernicke Breakdown of academic impact, for papers by Jana Drozenová Breakdown of academic impact, for papers by S. Suchetha Breakdown of academic impact, for papers by Hanmei Lou Breakdown of academic impact, for papers by Jennifer X. Ji Breakdown of academic impact, for papers by Hélène Vanacker Breakdown of academic impact, for papers by Elizabeth V. Connor Breakdown of academic impact, for papers by Ari Reiss Breakdown of academic impact, for papers by Yen‐Hou Chang Breakdown of academic impact, for papers by Eric Rios‐Doria
Rankless by CCL
2026